Key result
The Tenth Heart in Diabetes meeting highlighted that cardio-renal-metabolic care must integrate glucose, lipids, blood pressure, and organ dysfunction management across traditional specialty boundaries.
Why the study?
The complex interplay of diabetes, vascular disease, and heart failure in cardio-renal-metabolic patients requires integrated clinical management approaches beyond traditional disease silos.
The Tenth Heart in Diabetes meeting emphasized the necessity of a coordinated, cross-specialty approach to cardio-renal-metabolic (CRM) disease, integrating the management of glucose, lipids, blood pressure, weight, and heart failure.
Supports integrated cardio-renal-metabolic care across specialties; extends AHA CKM framework yet leaves open prospective outcome validation.
The Tenth Heart in Diabetes (HiD) meeting, held in Philadelphia, Pennsylvania, June 19-21, 2026, offered a clinical approach to the complex cardio-renal-metabolic (CRM) patient.Features of CRM disease include diabetes, insulin resistance, obesity, chronic kidney disease, atherosclerosis, heart failure, fatty liver disease, vascular inflammation, and neurohormonal activation, typically with multiple coexisting conditions which interact biologically and increasingly share treatments.
No takes yet. Share an insight, caveat, or question.
Bloomgarden et al. (2026) conducted a review in Cardio-renal-metabolic (CRM) disease. The Tenth Heart in Diabetes meeting highlighted that cardio-renal-metabolic care must integrate glucose, lipids, blood pressure, and organ dysfunction management across traditional specialty boundaries.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: